How a Costco accomplice’s chapter may benefit its largest rival

I’ve coated two chapter tales earlier than. Not from the standard angle of what occurred and why; for every, I dug deeper into who might win from the wreckage.

The Magellan Aerospace story led me to Howmet. The IKEA retailer closures pointed me to Goal. This week’s Chapter 11 submitting from Focus Issue maker Synergy CHC Corp. factors me squarely to Reckitt Benckiser (RBGLY).

Synergy CHC filed for chapter on September 4, 2026, within the U.S. Chapter Courtroom for the District of Columbia, TheStreet reported.

Costco informed the corporate again in July that it will be discontinuing Focus Issue merchandise after a 16-year relationship. You see that one choice? It value Synergy roughly 58% of its whole 2025 internet income, triggered an $18.9 million debt acceleration from its lender, and made Chapter 11 inevitable.

RBGLY at present trades at $14, down 10.62% year-to-date, in response to Yahoo Finance.

How a 58% income focus turns into a deadly single level of failure

The Synergy CHC scenario exhibits simply how rapidly retail focus can turn out to be a threat. Focus Issue is a useful beverage model with a 25-year legacy, having fun with established distribution within the U.S., Canada, and Mexico, and distribution throughout Walmart, Walgreens, Amazon, and BJ’s.

The corporate’s a mind complement with nutritional vitamins, minerals, and neuro-nutrients. It carries a “#1 Pharmacist Really useful” declare from the 2025-2026 U.S. Pharmacy Instances survey for reminiscence assist. None of that mattered as soon as Costco made its choice.

Extra Retail:

“Costco accounted for roughly 58% of the Firm’s internet income through the fiscal yr ended December 31, 2025,” the SEC submitting said. “The Firm expects Costco’s choice to have a cloth antagonistic impact on the Firm’s enterprise, outcomes of operations, liquidity, and monetary situation.”

Costco didn’t give a public motive for dropping the model. It didn’t must. It is a retailer that strikes merchandise in bulk, and it made its vendor choice for no matter motive.

The $18.9 million debt acceleration that adopted confirmed Synergy had no monetary cushion to outlive even a short lived income disruption of this magnitude.

Why I believe Reckitt’s Neuriva is the plain beneficiary

Three structural benefits make Reckitt the clearest winner.

Neuriva is already in Costco’s system. The Neuriva Mind Complement Unique (50 capsules) at present retails at Costco for $43.99. Reckitt doesn’t must win a vendor slot or navigate Costco’s notoriously demanding provider necessities. It’s already accredited, built-in, and promoting. Scaling quantity inside an present provider relationship is operationally simple.
Reckitt’s product portfolio suits neatly into the place Costco needs to go. Costco members are likely to gravitate towards premium wellness merchandise backed by established manufacturers and analysis. Reckitt has been aggressively increasing Neuriva, with merchandise together with Neuriva Plus, Neuriva Extremely, and Neuriva Reminiscence 3D. I see these premium formulations align with Costco’s push towards higher-margin well being options much better than the legacy Focus Issue lineup.
The regulatory historical past issues, too. Focus Issue has confronted FTC settlements and client class-action lawsuits difficult its efficacy claims. Reckitt builds Neuriva’s advertising round clinically studied components and GMO-free formulations.

After dropping a model with that compliance historical past, Costco’s purchaser relationships will naturally favor an institutional, publicly traded client well being firm with a clear regulatory document.

The Neuriva Mind Complement Unique (50 capsules) at present retails at Costco for $43.99.BearFotos By way of Shutterstock

The Reckitt enterprise image and what the H1 2026 outcomes present

The enterprise image issues for traders contemplating whether or not RBGLY at $14.00 and down 10.62% year-to-date represents a chance. Whereas its main itemizing is on the London Inventory Trade (RKT), it’s extremely seen to U.S. market traders through its American Depositary Receipts (ADRs) below the ticker RBGLY on the over-the-counter market.

Half-year 2026 (H1 2026) outcomes confirmed Core Reckitt like-for-like internet income progress of two.7%, accelerating to 4.2% in Q2 alone, in response to Reckitt’s earnings assertion.

Gross revenue margin for Core Reckitt was 60.9%. Adjusted working revenue margin was 24.8%. Free money circulate was £419 million within the first half. Roughly £3 billion was returned to shareholders through the interval by means of dividends and buybacks, in response to the Q2 earnings name.

Associated: Lack of Costco deal helps push beverage model into Chapter 11

Reckitt additionally introduced a 5% improve in its interim dividend alongside an extra £500 million share buyback. Full-year 2026 steerage requires 4% to five% like-for-like internet income progress in Core Reckitt.

A particular dividend was additionally paid in February 2026 following the completion of the Important Home-based business divestment, returning extra capital to shareholders.

Macrotrends‘ statistics present RBGLY with a 4.6% dividend yield at present costs, with the latest dividend of $0.64 per share.

The valuation image can be honest: trailing P/E of 11.36 and ahead P/E of 14.24 for a corporation with 60.9% gross margins, a rising client well being platform, and direct aggressive beneficiary of its largest mind well being competitor’s collapse.

What to look at for subsequent at Costco

Synergy CHC constructed a robust model on a structurally fragile basis. The focus threat was seen within the filings lengthy earlier than the chapter. After which when Costco walked, the mathematics grew to become inevitable.

I believe Reckitt has all it takes. The Costco shelf presence, regulatory credibility, provide chain, and product portfolio to soak up that demand with out including structural threat.

All of that and extra is more likely to translate to RBGLY’s monetary outcomes, relying on how aggressively Costco scales up Neuriva alongside the general product developments.

Associated: Costco asks members to assist make shops higher

This story was initially revealed by TheStreet on Sep 15, 2026, the place it first appeared within the Investing part. Add TheStreet as a Most well-liked Supply by clicking right here.